InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: SF Anony post# 142127

Thursday, 01/21/2021 3:58:47 PM

Thursday, January 21, 2021 3:58:47 PM

Post# of 233271

completely miss such an obvious signal that the trial was under-powered

It wouldn't be underpowered if the results were spectacular but it would be underpowered if the results are marginally good. The odds of the results being spectacular are slim. Leronlimab is a mild drug. The good part of that is that there are few to no side effects. The bad part is that a mild drug isn't powerful enough to have bold effects.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News